San Diego, CA, United States of America

Krishna Kannan

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Codex Dna, Inc., Etonbio, Inc., Telesis Bio Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Krishna Kannan. Retrieved from https://idiyas.com/inventor/krishna-kannan-3jqztjsf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 7.2

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Krishna Kannan in San Diego, CA**

Introduction

Krishna Kannan is a prolific inventor based in San Diego, California, renowned for his contributions to the field of synthetic genomics. With a total of three patents to his name, Kannan continues to push the boundaries of genetic engineering and synthetic biology, making significant strides that could impact various applications in biotechnology.

Latest Patents

Among his latest innovations, Kannan has developed groundbreaking methods for generating synthetic genomes. His first notable patent, titled "Methods for generating synthetic genomes," outlines techniques for creating synthetic genomes that possess desired properties, including viable genomes of reduced size. These innovations not only help in enhancing our understanding of genomics but also facilitate the development of synthetic cells that can carry these genomes.

Another significant contribution by Kannan involves the "Demand synthesis of polynucleotide sequences." This invention details methods for effectively synthesizing DNA molecules with specific and defined sequences, allowing for complex assemblies of oligonucleotides derived from libraries with less than 20,000 members. This capability is vital in crafting a myriad of possible DNA sequences for diverse applications.

Career Highlights

Throughout his career, Krishna Kannan has been associated with forward-thinking companies such as Codex DNA, Inc. and Telesis Bio Inc. His work in these firms underscores his commitment to advancing the field of synthetic biology through innovative research and practical applications designed to optimize DNA synthesis and genome construction.

Collaborations

Kannan has collaborated with prominent figures in his field, including Clyde A. Hutchison and Ray-Yuan Chuang. These partnerships have not only enriched his research endeavors but have also facilitated the sharing of knowledge and expertise, driving forward the development of cutting-edge technologies in the life sciences.

Conclusion

In conclusion, Krishna Kannan represents the pioneering spirit of modern inventors. His innovative approaches to synthetic genome generation and DNA synthesis reflect a deep commitment to unlocking the potential of genetics. As he continues to forge new paths in synthetic biology, Kannan's work holds the promise of transformative implications for health, agriculture, and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…